awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36318226-6FFBBACB-943A-41E7-9F9D-E6E61FD96B7C
Q36318226-6FFBBACB-943A-41E7-9F9D-E6E61FD96B7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36318226-6FFBBACB-943A-41E7-9F9D-E6E61FD96B7C
Resistance to Trastuzumab in Breast Cancer.
P2860
Q36318226-6FFBBACB-943A-41E7-9F9D-E6E61FD96B7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36318226-6FFBBACB-943A-41E7-9F9D-E6E61FD96B7C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abac3998f3ac5ef4ba317922aa167e626c005f68
P2860
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.